Opicapone could help people whose main Parkinson’s medications are "wearing off" before the next dose is due, a common problem which has a huge impact on quality of life.
Blow away those new year blues and get involved in the Parkinson’s community.
It’s been another tough year. Especially if you, or someone you love, has Parkinson’s. But we’re learning to live with coronavirus, adapting our vital support services and finding new ways to come together as a community.
We’ve teamed up with leading patient engagement organisations COUCH Health and Egality Health to make Parkinson’s research more accessible, relevant and inclusive.
If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
We’re investing in research into inflammation that could help develop drugs that slow the progression of Parkinson’s, something no current medication can do.
The UK government has published its long-awaited White Paper on social care reform in England, People at the Heart of Care.
The co-chairs of the All-Party Parliamentary Group on Parkinson's share their support for Disability History Month
The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.